These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3057000)

  • 21. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
    Woodley DT; Briggaman RA; O'Keefe EJ; Inman AO; Queen LL; Gammon WR
    N Engl J Med; 1984 Apr; 310(16):1007-13. PubMed ID: 6369131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer.
    Furue M; Iwata M; Yoon HI; Kubota Y; Ohto H; Kawashima M; Tsuchida T; Oohara K; Tamaki K; Kukita A
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):873-8. PubMed ID: 3086389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A.
    Merle C; Blanc D; Zultak M; van Landuyt H; Drobacheff C; Laurent R
    Dermatologica; 1990; 181(1):44-7. PubMed ID: 2394303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunopathology of epidermolysis bullosa acquisita.
    Kushniruk W
    Can Med Assoc J; 1973 May; 108(9):1143-6. PubMed ID: 4574408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearing of epidermolysis bullosa acquisita with cyclosporine.
    Crow LL; Finkle JP; Gammon WR; Woodley DT
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 2):937-42. PubMed ID: 3057000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature.
    Arpey CJ; Elewski BE; Moritz DK; Gammon WR
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):706-14. PubMed ID: 1869641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermolysis bullosa acquisita.
    Gammon WR
    Semin Dermatol; 1988 Sep; 7(3):218-24. PubMed ID: 3153447
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging treatment for epidermolysis bullosa acquisita.
    Engineer L; Ahmed AR
    J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of epidermolysis bullosa acquisita.
    Intong LR; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):643-7. PubMed ID: 21925011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen.
    Woodley DT; Briggaman RA; Gammon WR
    Dermatol Clin; 1990 Oct; 8(4):717-26. PubMed ID: 2249362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases.
    Roenigk HH; Ryan JG; Bergfeld WF
    Arch Dermatol; 1971 Jan; 103(1):1-10. PubMed ID: 4321800
    [No Abstract]   [Full Text] [Related]  

  • 35. When to request immunofluorescence: practical hints.
    Morrison LH
    Semin Cutan Med Surg; 1999 Mar; 18(1):36-42. PubMed ID: 10188840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermolysis bullosa acquisita: update and review.
    Hallel-Halevy D; Nadelman C; Chen M; Woodley DT
    Clin Dermatol; 2001; 19(6):712-8. PubMed ID: 11705680
    [No Abstract]   [Full Text] [Related]  

  • 37. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.
    Yang WS; Kang S; Sung J; Kleinman HK
    Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune blistering diseases in females: a review.
    Zhao CY; Murrell DF
    Int J Womens Dermatol; 2015 Feb; 1(1):4-12. PubMed ID: 28491949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa.
    Garcia-Doval I; Davila-Seijo P; Langan SM
    Clin Exp Dermatol; 2013 Jan; 38(1):92-4. PubMed ID: 22731863
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.